These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 16759872)

  • 1. Synthesis of novel 5-substituted indirubins as protein kinases inhibitors.
    Beauchard A; Ferandin Y; Frère S; Lozach O; Blairvacq M; Meijer L; Thiéry V; Besson T
    Bioorg Med Chem; 2006 Sep; 14(18):6434-43. PubMed ID: 16759872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for the synthesis of indirubins as potent and selective inhibitors of glycogen synthase kinase-3 and cyclin-dependent kinases.
    Polychronopoulos P; Magiatis P; Skaltsounis AL; Myrianthopoulos V; Mikros E; Tarricone A; Musacchio A; Roe SM; Pearl L; Leost M; Greengard P; Meijer L
    J Med Chem; 2004 Feb; 47(4):935-46. PubMed ID: 14761195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-Bromoindirubin-3'-oxime induces caspase-independent cell death.
    Ribas J; Bettayeb K; Ferandin Y; Knockaert M; Garrofé-Ochoa X; Totzke F; Schächtele C; Mester J; Polychronopoulos P; Magiatis P; Skaltsounis AL; Boix J; Meijer L
    Oncogene; 2006 Oct; 25(47):6304-18. PubMed ID: 16702956
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
    Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
    Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organometallic compounds with biological activity: a very selective and highly potent cellular inhibitor for glycogen synthase kinase 3.
    Atilla-Gokcumen GE; Williams DS; Bregman H; Pagano N; Meggers E
    Chembiochem; 2006 Sep; 7(9):1443-50. PubMed ID: 16858717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and cytotoxicity of novel indirubin-5-carboxamides.
    Cheng X; Rasqué P; Vatter S; Merz KH; Eisenbrand G
    Bioorg Med Chem; 2010 Jun; 18(12):4509-15. PubMed ID: 20488718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, kinase inhibitory potencies and in vitro antiproliferative activity of isoindigo and 7'-azaisoindigo derivatives substituted by Sonogashira cross-coupling.
    Bouchikhi F; Anizon F; Moreau P
    Eur J Med Chem; 2009 Jun; 44(6):2705-10. PubMed ID: 19232788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thiazolo[5,4-f]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3.
    Testard A; Logé C; Léger B; Robert JM; Lozach O; Blairvacq M; Meijer L; Thiéry V; Besson T
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3419-23. PubMed ID: 16644220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble 3',6-substituted indirubins with enhanced selectivity toward glycogen synthase kinase -3 alter circadian period.
    Vougogiannopoulou K; Ferandin Y; Bettayeb K; Myrianthopoulos V; Lozach O; Fan Y; Johnson CH; Magiatis P; Skaltsounis AL; Mikros E; Meijer L
    J Med Chem; 2008 Oct; 51(20):6421-31. PubMed ID: 18816110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activities of aminopyrimidyl-indoles structurally related to meridianins.
    Akue-Gedu R; Debiton E; Ferandin Y; Meijer L; Prudhomme M; Anizon F; Moreau P
    Bioorg Med Chem; 2009 Jul; 17(13):4420-4. PubMed ID: 19477650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and kinase inhibitory activity of novel substituted indigoids.
    Beauchard A; Laborie H; Rouillard H; Lozach O; Ferandin Y; Le Guével R; Guguen-Guillouzo C; Meijer L; Besson T; Thiéry V
    Bioorg Med Chem; 2009 Sep; 17(17):6257-63. PubMed ID: 19665384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?
    Leclerc S; Garnier M; Hoessel R; Marko D; Bibb JA; Snyder GL; Greengard P; Biernat J; Wu YZ; Mandelkow EM; Eisenbrand G; Meijer L
    J Biol Chem; 2001 Jan; 276(1):251-60. PubMed ID: 11013232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein kinase 3.
    Efstathiou A; Gaboriaud-Kolar N; Smirlis D; Myrianthopoulos V; Vougogiannopoulou K; Alexandratos A; Kritsanida M; Mikros E; Soteriadou K; Skaltsounis AL
    Parasit Vectors; 2014 May; 7():234. PubMed ID: 24886176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-mitotic properties of indirubin-3'-monoxime, a CDK/GSK-3 inhibitor: induction of endoreplication following prophase arrest.
    Damiens E; Baratte B; Marie D; Eisenbrand G; Meijer L
    Oncogene; 2001 Jun; 20(29):3786-97. PubMed ID: 11439342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of novel aza-1,7-annulated indoles and their conversion to potent indolocarbazole kinase inhibitors.
    Al-awar RS; Ray JE; Hecker KA; Joseph S; Huang J; Shih C; Brooks HB; Spencer CD; Watkins SA; Schultz RM; Considine EL; Faul MM; Sullivan KA; Kolis SP; Carr MA; Zhang F
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3925-8. PubMed ID: 15225699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From Tyrian purple to kinase modulators: naturally halogenated indirubins and synthetic analogues.
    Vougogiannopoulou K; Skaltsounis AL
    Planta Med; 2012 Sep; 78(14):1515-28. PubMed ID: 22972384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of novel 7-azaindazolyl-indolyl-maleimide derivatives as antitumor agents and protein kinase C inhibitors.
    Ye Q; Cao J; Zhou X; Lv D; He Q; Yang B; Hu Y
    Bioorg Med Chem; 2009 Jul; 17(13):4763-72. PubMed ID: 19447039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of glycogen synthase kinase-3 inhibitors with a selective sting for glycogen synthase kinase-3α.
    Lo Monte F; Kramer T; Gu J; Anumala UR; Marinelli L; La Pietra V; Novellino E; Franco B; Demedts D; Van Leuven F; Fuertes A; Dominguez JM; Plotkin B; Eldar-Finkelman H; Schmidt B
    J Med Chem; 2012 May; 55(9):4407-24. PubMed ID: 22533818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of new dipyrrolo- and furopyrrolopyrazinones related to tripentones and their biological evaluation as potential kinases (CDKs1-5, GSK-3) inhibitors.
    Rochais C; Duc NV; Lescot E; Sopkova-de Oliveira Santos J; Bureau R; Meijer L; Dallemagne P; Rault S
    Eur J Med Chem; 2009 Feb; 44(2):708-16. PubMed ID: 18586356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,5-Diaminopyrimidines and 3,5-disubstituted azapurines as inhibitors of glycogen synthase kinase-3 (GSK-3).
    Lum C; Kahl J; Kessler L; Kucharski J; Lundström J; Miller S; Nakanishi H; Pei Y; Pryor K; Roberts E; Sebo L; Sullivan R; Urban J; Wang Z
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3578-81. PubMed ID: 18502127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.